<DOC>
	<DOC>NCT00160186</DOC>
	<brief_summary>The purpose of this study is to investigate BMI and the nutritional parameters of Creon (pancreatin) versus placebo after a total or subtotal gastrectomy.</brief_summary>
	<brief_title>Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy</brief_title>
	<detailed_description />
	<mesh_term>Pancreatin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Informed consent Males or females Age &gt;= 18 years Total or subtotal gastrectomy Females having negative pregnancy test or being surgically sterile or 1 year postmenopausal; women of childbearing age must use effective birth control. Diseases or conditions limiting the participation in, or completion of, the study Progressive tumors/metastasis Complications leading to insufficient peroral nutrition Known allergy to pancreatin Known exocrine insufficiency Experimental drug intake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>